Indivior: High‐dose bupe could help fentanyl addiction

Based on a presentation at the June College on Problems of Drug Dependence (CPDD) Annual Scientific Meeting, manufacturer Indivior has shown that patients with heavier fentanyl use experienced clinically meaningful improvements in opioid abstinence when treated with a 300 mg maintenance dose of Sublocade, compared to the 100 mg dose.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2025-09-26
DOI
https://doi.org/10.1002/adaw.34666
Primary Topic
Cancer, Stress, Anesthesia, and Immune Response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Indivior: High‐dose bupe could help fentanyl addiction

Alison Knopf
Alcoholism & Drug Abuse Weekly
Cancer, Stress, Anesthesia, and Immune Response
article

Indivior: High‐dose bupe could help fentanyl addiction

Alison Knopf
article en

Abstract

Based on a presentation at the June College on Problems of Drug Dependence (CPDD) Annual Scientific Meeting, manufacturer Indivior has shown that patients with heavier fentanyl use experienced clinically meaningful improvements in opioid abstinence when treated with a 300 mg maintenance dose of Sublocade, compared to the 100 mg dose.

Alcoholism & Drug Abuse WeeklyVol. 37(37)
Openalex Percentile: Top 69%
Cancer, Stress, Anesthesia, and Immune Response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Indivior: High‐dose bupe could help fentanyl addiction — Alison Knopf · Alcoholism & Drug Abuse Weekly (2025) | TGRS Research Map | TGRS